April 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreApril 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreApril 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
According to market projections, the global gene overexpression cell line construction market, valued at USD 788.63 million in 2024, is anticipated to reach USD 1,629.93 million by 2034, growing at a CAGR of 7.53% over the next decade. The versatility of an overexpression research tool makes it popular among wild-type and mutant research. North Ame...
April 21, 2026
Projections indicate that, cell and gene therapy CRO industry is projected to rise from USD 4.90 billion in 2024 to USD 12.59 billion by 2034, reflecting a CAGR of 9.9% over the next decade. The cell and gene therapy CRO market is growing as CROs work with cell and gene therapies targeting a wide array of diseases, cancer, rare and inherited geneti...
April 21, 2026
Projections indicate that, the global cell and gene therapy cold chain logistics market will increase from USD 1.89 billion in 2024 to USD 8.06 billion by 2034, experiencing a CAGR of 15.64% over the next 10 years. The cell and gene therapy cold chain logistics market is expanding due to advancing cold chain technologies as well as increasing cell ...
April 21, 2026
Based on market forecasts, the global cell and gene therapy manufacturing QC market, projected at USD 2.66 billion in 2024, is expected to reach USD 12.35 billion by 2034, growing at a CAGR of 16.89% over the forecast period. The growing demand for cell and gene therapy and stringent regulatory policies drive the global market. North America domina...
April 21, 2026
Based on market forecasts, the global cell and gene supply chain solutions market, projected at USD 3.54 billion in 2024, is expected to reach USD 14.95 billion by 2034, growing at a CAGR of 15.54% over the forecast period. The cell and gene supply chain solutions market is growing due to the rising need for personalized therapies. North America&rs...
April 21, 2026
The rising prevalence of chronic disorders and advancements in genomic technologies bolster market growth. North America led the global market owing to the growing demand for biologics and the presence of key players....
April 21, 2026
Projections indicate that, digital health insurance industry is projected to rise from USD 3.57 trillion in 2024 to USD 11.11 trillion by 2034, reflecting a CAGR of 12.05% over the next decade. The global customer-driven demand for convenience, personalization, and technological innovation supports the expansive reach of digital health insurance se...
April 21, 2026
According to forecasts, the global clinical trial central lab services market will grow from USD 4.13 billion in 2024 to USD 10.54 billion by 2034, with an expected CAGR of 9.84%. The increasing number of clinical trials and the growing demand for advanced assays drive the global market. North America dominated the global market due to a favorable ...
April 21, 2026
The behavioral mental health market is expanding due to growing digital platforms as well as increasing use of ketamine therapies. North America led the market due to the presence of a strong healthcare sector....
April 21, 2026
The global market is driven by the increasing healthcare costs and awareness. North America led due to the presence of robust value-based care models in CCM....